IOVA:NASDAQ
Iovance Biotherapeutics Inc
$9.36
arrow_upward
+1.08%(+0.100) 1D
$9.39
arrow_upward
+0.32% (+0.030)bedtimeAfter hours
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IOVA...
Open
$9.21
High
$9.38
Low
$8.98
Mkt. cap
4.24B
Avg. vol.
17.05M
Volume
11.09M
52-wk high
$9.40
52-wk low
$1.76
EPS
-$0.72
Beta
0.83
Shares outstanding
452.97M
No. of employees
975
Open
$9.21
High
$9.38
Low
$8.98
Mkt. cap
4.24B
Avg. vol.
17.05M
Volume
11.09M
52-wk high
$9.40
52-wk low
$1.76
EPS
-$0.72
Beta
0.83
Shares outstanding
452.97M
No. of employees
975
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
IOVA Flags Year-End Data Slate After Record Amtagvi Quarter, Highlights ‘Clear Line Of Sight To Profitability’
Yahoo Finance
·
21 hours ago
SLS, IBRX, IOVA In Focus Amid Big Pharma’s Early Cancer-Asset Hunt: J&J Flags M&A ‘Sweet Spot,’ Pfizer Eyes Phase 1-2 Deals
Investing.com
·
1 day ago
Iovance Biotherapeutics stock hits 52-week high at 9.36 USD
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com